21:11:49 EDT Sun 06 Jul 2025
Enter Symbol
or Name
USA
CA



News for U:ARAY from 2024-07-05 to 2025-07-04 - 27 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2025-06-06 07:30U:ARAYNews ReleaseAccuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities
2025-05-29 19:30U:ARAYNews ReleaseAccuray to Participate in the Jefferies Global Healthcare Conference 2025
2025-05-07 07:35U:ARAYNews ReleaseAccuray Showcases New Long-Term Data Superscript 1 on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
2025-05-05 16:10U:ARAYNews ReleaseAccuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife(TM) System
2025-04-30 16:05U:ARAYNews ReleaseAccuray Reports Fiscal 2025 Third Quarter Financial Results
2025-04-16 16:05U:ARAYNews ReleaseAccuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025
2025-04-03 07:35U:ARAYNews ReleaseAccuray CyberKnife(TM) Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting
2025-03-12 07:30U:ARAYNews ReleaseAccuray to Participate at 37th Annual Roth Conference
2025-02-05 16:05U:ARAYNews ReleaseAccuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance
2025-01-23 07:35U:ARAYNews ReleaseAccuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo(TM) C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
2025-01-22 16:05U:ARAYNews ReleaseAccuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025
2025-01-21 09:15U:ARAYNews ReleaseLeonel Peralta to Join Accuray as Chief Operations Officer
2025-01-13 15:00U:ARAYNews ReleaseAccuray Announces China National Medical Products Administration Approval of the Radixact(TM) SynC(TM) and CyberKnife(TM) S7(TM) Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo(TM) C System
2024-12-18 07:35U:ARAYNews ReleaseNew Data Indicates the CyberKnife(TM) System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
2024-11-26 16:03U:ARAYNews ReleaseAccuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
2024-11-06 16:05U:ARAYNews ReleaseAccuray Reports Fiscal 2025 First Quarter Financial Results
2024-10-23 16:05U:ARAYNews ReleaseAccuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
2024-10-21 16:05U:ARAYNews ReleaseAccuray Appoints Michael Murphy as VP, Corporate Controller
2024-10-17 07:00U:ARAYNews ReleaseNew England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men with Localized Prostate Cancer
2024-10-15 08:45U:ARAYNews ReleaseAccuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence
2024-09-30 07:35U:ARAYNews ReleaseAccuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife(TM) S7(TM) System Medical Professional Training
2024-09-10 17:30U:ARAYNews ReleaseGifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact(TM) System and VitalHold(TM) Solution
2024-09-03 16:10U:ARAYNews ReleaseAccuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence
2024-08-27 07:35U:ARAYNews ReleaseAccuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix(TM)
2024-08-14 16:05U:ARAYNews ReleaseAccuray Reports Fourth Quarter and Fiscal 2024 Financial Results
2024-08-13 07:35U:ARAYNews ReleaseHalifax Health in Florida is First in the U.S. to Treat Patients with Cancer Using the Accuray Radixact(TM) Radiation Delivery System and VitalHold(TM) Technology
2024-07-31 16:05U:ARAYNews ReleaseAccuray to Report Fourth Quarter Fiscal 2024 Financial Results on August 14, 2024